Morgan Stanley

Selected news for the capital firm - Morgan Stanley, collected since 10/2017. Recent stories appear in Daily Political and baseballnewssource.com. This capital firm shares healthcare news with Medical Research, Wolfe Research, CVS Health, CVS, Pfizer and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
7/21/2021 Stocks That Hit 52-Week Highs On Wednesday | Benzinga Benzinga ... on Wednesday morning to hit a new 52-week high of $90.14. Coca-Cola (NYSE: KO ) stock made a new 52-week high of $57.56 Wednesday. The stock was up 1.88% for the day. Morgan Stanley (NYSE: MS ) shares set a new 52-week high of $94.35 on Wednesday, moving up 1.2%. Target (NYSE: TGT ) shares were up 0.26% on Wednesday to hit a new 52-week high of $256.43 ...
7/21/2021 GoHealth (NASDAQ:GOCO) Hits New 12-Month Low at $9.57 - Ticker Report Ticker Report ... in a report on Monday, May 17th. Truist decreased their price target on GoHealth from $26.00 to $20.00 and set a “buy” rating for the company in a report on Thursday, May 13th. Morgan Stanley increased their price target on GoHealth from $13.00 to $14.00 and gave the stock an “equal weight” rating in a report on Friday, May 14th. Raymond James decreased their price target on GoHealth ...
7/21/2021 GoHealth (NASDAQ:GOCO) Sets New 52-Week Low at $9.57 - Watch List News watchlistnews.com ... traded as low as $9.57 and last traded at $9.65, with a volume of 2565 shares traded. The stock had previously closed at $9.88.A number of research analysts recently commented on GOCO shares. Morgan Stanley upped their price objective on GoHealth from $13.00 to $14.00 and gave the stock an “equal weight” rating in a research note on Friday, May 14th. Credit Suisse Group reduced their price target ...
7/20/2021 Verition Fund Management LLC Grows Position in Centene Co. (NYSE:CNC) - Ticker Report Ticker Report ... holdings in shares of Centene by 3.4% State of Wisconsin Investment Board now owns 450,908 shares of the company’s stock valued at $28,818,000 after acquiring an additional 14,724 shares in the last quarter. Morgan Stanley increased its holdings in Centene by 27.6% in the 1st quarter. Morgan Stanley now owns 1,991,298 shares of the company’s stock worth $127,264,000 after buying an additional 430,958 Alyeska Investment Group L.P. increased ...
7/20/2021 Shore Capital Reaffirms House Stock Rating for Bonhill Group (LON:BONH) | Daily Political Daily Political ... have also issued reports about the stock. HC Wainwright reissued a “buy” rating and issued a $35.00 target price (down from $47.00) on shares of Exelixis in a report on Tuesday, June 29th. Morgan Stanley lowered their price target on Exelixis from $27.00 to $26.00 and set an “equal weight” rating for the company in a research report on Monday, April 19th. TheStreet downgraded Exelixis from a “b ...
7/20/2021 Hookipa Pharma (NASDAQ:HOOK) Stock Rating Upgraded by Zacks Investment Research thelincolnianonline.com ... platform which is designed to reprogram the body’s immune system. HOOKIPA Pharma Inc. is based in New York, United States. “ Other equities analysts have also recently issued research reports about the stock. Morgan Stanley assumed coverage on shares of Hookipa Pharma in a report on Thursday, April 8th. They issued an overweight rating and a $19.00 target price on the stock. TheStreet cut shares of Hookipa Pharma from ...
7/20/2021 Morgan Stanley Boosts Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $224.00 - Mayfield Recorder Mayfield Recorder Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target boosted by Morgan Stanley from $205.00 to $224.00 in a research report sent to investors on Friday, Analyst Price Targets reports. The brokerage currently has an overweight rating on the biopharmaceutical company’s stock.Separately, Needham & Company LLC restated a buy rating on shares of Alnylam Pharmaceuticals in a report on Tuesday, April 20th. Seven equities research analysts have rated the stock ...
7/20/2021 Morgan Stanley Raises Ironwood Pharmaceuticals (NASDAQ:IRWD) Price Target to $12.00 - The Cerbat Gem thecerbatgem.com Ironwood Pharmaceuticals (NASDAQ:IRWD) had its target price upped by Morgan Stanley from $11.00 to $12.00 in a research report released on Friday, Analyst Price Targets reports. Morgan Stanley currently has an equal weight rating on the biotechnology company’s stock.A number of other brokerages have also recently commented on IRWD. Northland Securities reiterated a buy rating and set a $15.00 target price on shares of Ironwood Pharmaceuticals in ...
7/20/2021 Hookipa Pharma (NASDAQ:HOOK) Upgraded by Zacks Investment Research to Buy com-unik.info ... which is designed to reprogram the body’s immune system. HOOKIPA Pharma Inc. is based in New York, United States. “ A number of other research analysts have also issued reports on the company. Morgan Stanley initiated coverage on Hookipa Pharma in a report on Thursday, April 8th. They issued an overweight rating and a $19.00 target price for the company. HC Wainwright lifted their target price on Hookipa Pharma ...
7/20/2021 Morgan Stanley Raises Ironwood Pharmaceuticals (NASDAQ:IRWD) Price Target to $12.00 com-unik.info Ironwood Pharmaceuticals (NASDAQ:IRWD) had its price objective lifted by Morgan Stanley from $11.00 to $12.00 in a report released on Friday morning, PriceTargets.com reports. They currently have an equal weight rating on the biotechnology company’s stock. IRWD has been the topic of several other research reports. Zacks Investment Research raised Ironwood Pharmaceuticals from a sell rating to a buy rating and set a $11.00 target price on the ...
7/20/2021 Cadence Bancorporation (CADE) to Release Quarterly Earnings on Thursday | Daily Political Daily Political Morgan Stanley Lowers Biogen (NASDAQ:BIIB) Price Target to $453.00 Posted by Tyrone Williams on Jul 19th, 2021 Share on StocktwitsBiogen (NASDAQ:BIIB) had its price target trimmed by Morgan Stanley from $455.00 to $453.00 in a research note published on Friday, PriceTargets.com reports. The firm currently has an overweight rating on the biotechnology company’s stock.Several other research analysts have also commented on BIIB. The Goldman Sachs ...
7/20/2021 Morgan Stanley Lowers Biogen (NASDAQ:BIIB) Price Target to $453.00 - Ticker Report Ticker Report Biogen (NASDAQ:BIIB) had its target price cut by Morgan Stanley from $455.00 to $453.00 in a research report report published on Friday morning, Analyst Ratings Network reports. They currently have an overweight rating on the biotechnology company’s stock.Other equities analysts have also recently issued research reports about the stock. William Blair raised shares of Biogen from a market perform rating to an outperform rating in a research ...
7/20/2021 Coupa Software (NASDAQ:COUP) Hits New 52-Week Low Following Analyst Downgrade theenterpriseleader.com Coupa Software Incorporated (NASDAQ:COUP)’s share price reached a new 52-week low during trading on Monday after Morgan Stanley lowered their price target on the stock from $381.00 to $345.00. Morgan Stanley currently has an overweight rating on the stock. Coupa Software traded as low as $213.00 and last traded at $213.00, with a volume of 1 shares changing hands. The stock had previously closed at $217.54. Several ...
7/20/2021 Brokers Offer Predictions for Lockheed Martin Co.'s FY2021 Earnings (NYSE:LMT) - The Cerbat Gem thecerbatgem.com ... They issued a “peer perform” rating for the company. Cowen reaffirmed a “buy” rating and issued a $410.00 target price on shares of Lockheed Martin in a report on Thursday, April 22nd. Morgan Stanley upped their target price on shares of Lockheed Martin from $445.00 to $458.00 and gave the stock an “overweight” rating in a report on Wednesday, April 21st. Finally, Wells Fargo & Company started coverage ...
7/20/2021 UDR, Inc. (NYSE:UDR) Forecasted to Earn Q2 2022 Earnings of $0.51 Per Share - Ticker Report Ticker Report ... the quarter, missing the Zacks’ consensus estimate of $0.47 by ($0.46). UDR had a net margin of 5.09% and a return on equity of 2.76%.Several other brokerages have also commented on UDR. Morgan Stanley raised their price target on UDR from $56.00 to $58.00 and gave the company an “overweight” rating in a research note on Thursday, July 15th. Wolfe Research started coverage on UDR in a ...
7/20/2021 Shopify (NYSE:SHOP) Price Target Raised to $2,000.00 - Mayfield Recorder Mayfield Recorder ... number of other research reports. Wolfe Research started coverage on shares of Shopify in a research report on Wednesday, March 31st. They set an outperform rating and a $1,360.00 target price on the stock. Morgan Stanley boosted their price target on shares of Shopify from $1,300.00 to $1,400.00 and gave the company an equal weight rating in a report on Thursday, April 29th. Royal Bank of Canada boosted their price ...
7/20/2021 Fifth Third Bancorp (NASDAQ:FITB) Earns Hold Rating from Analysts at Citigroup com-unik.info ... also issued reports about the company. Wolfe Research boosted their price objective on Fifth Third Bancorp from $40.00 to $45.00 and gave the company an outperform rating in a report on Thursday, March 25th. Morgan Stanley lifted their target price on Fifth Third Bancorp from $45.00 to $48.00 and gave the company an overweight rating in a research note on Thursday, April 29th. Deutsche Bank Aktiengesellschaft lifted their target price ...
7/20/2021 Coupa Software (NASDAQ:COUP) Rating Reiterated by Needham & Company LLC dispatchtribunal.com ... research note released on Friday, TipRanks reports. Needham & Company LLC currently has a $280.00 price objective on the technology company’s stock. COUP has been the subject of a number of other research reports. Morgan Stanley dropped their price objective on Coupa Software from $381.00 to $345.00 and set an overweight rating for the company in a report on Friday. Truist dropped their price objective on Coupa Software from $386.00 ...
7/20/2021 Coupa Software (NASDAQ:COUP) Rating Reiterated by Needham & Company LLC thelincolnianonline.com ... also recently issued reports on COUP. KeyCorp reduced their price target on shares of Coupa Software from $350.00 to $300.00 and set an overweight rating for the company in a research report on Friday. Morgan Stanley reduced their price target on shares of Coupa Software from $381.00 to $345.00 and set an overweight rating for the company in a research report on Friday. Raymond James set a $220.06 price target ...
7/20/2021 Critical Comparison: PowerFleet (NASDAQ:PWFL) versus ALR Technologies (OTCMKTS:ALRT) | Daily Political Daily Political ... price target for the company. UBS Group began coverage on shares of Alignment Healthcare in a report on Tuesday, April 20th. They set a neutral rating and a $28.00 price objective for the company. Morgan Stanley raised their price objective on shares of Alignment Healthcare from $36.00 to $38.00 and gave the stock an overweight rating in a report on Friday, July 2nd. Finally, Raymond James raised their price objective ...